drugset / Trial / NCT06260072
Magnesium and Riboflavin Treatment for Post-Concussion Headache
RandomizedParallel-groupTriple-blindTreatment
Summary
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Timeline
- Start
- 2020-02-10
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Oxide | Small molecule | 400 mg | — |
| Comparator | Riboflavin | Other / unclassified | 100 mg | — |
Indications
No indication recorded.